A detailed history of Banco De Sabadell, S.A transactions in Novo Nordisk A S stock. As of the latest transaction made, Banco De Sabadell, S.A holds 20,671 shares of NVO stock, worth $2.95 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares
20,671
Previous 20,752 0.39%
Holding current value
$2.95 Million
Previous $2.15 Million 23.46%
% of portfolio
1.98%
Previous 1.63%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $8,270 - $11,009
-81 Reduced 0.39%
20,671 $2.65 Million
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $4,740 - $5,694
-54 Reduced 0.26%
20,752 $2.15 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $911,946 - $2 Million
10,028 Added 93.04%
20,806 $1.89 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $7,643 - $8,459
-49 Reduced 0.45%
10,778 $1.74 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $146,897 - $176,645
-1,110 Reduced 9.3%
10,827 $1.72 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $24,509 - $32,343
239 Added 2.04%
11,937 $1.62 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $144,730 - $177,616
-1,519 Reduced 11.49%
11,698 $1.16 Million
Q2 2022

Aug 11, 2022

SELL
$103.24 - $121.81 $36,340 - $42,877
-352 Reduced 2.59%
13,217 $1.47 Million
Q1 2022

May 12, 2022

BUY
$93.1 - $112.54 $90,865 - $109,839
976 Added 7.75%
13,569 $1.5 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $110,837 - $135,344
1,156 Added 10.11%
12,593 $1.41 Million
Q3 2021

Nov 04, 2021

SELL
$84.42 - $106.62 $71,503 - $90,307
-847 Reduced 6.9%
11,437 $1.1 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $54,263 - $67,977
802 Added 6.98%
12,284 $1.03 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $3.28 Million - $3.71 Million
-48,945 Reduced 81.0%
11,482 $777,000
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $43,189 - $49,888
676 Added 1.13%
60,427 $4.24 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $159,925 - $176,322
-2,511 Reduced 4.03%
59,751 $4.16 Million
Q2 2020

Aug 07, 2020

SELL
$58.54 - $67.94 $1.02 Million - $1.18 Million
-17,374 Reduced 21.82%
62,262 $4.08 Million
Q1 2020

May 14, 2020

SELL
$49.46 - $64.78 $523,336 - $685,437
-10,581 Reduced 11.73%
79,636 $4.78 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $32,209 - $37,635
646 Added 0.72%
90,217 $5.22 Million
Q3 2019

Nov 15, 2019

SELL
$47.54 - $53.43 $998,577 - $1.12 Million
-21,005 Reduced 19.0%
89,571 $4.64 Million
Q2 2019

Aug 13, 2019

BUY
$46.79 - $52.47 $271,335 - $304,273
5,799 Added 5.53%
110,576 $5.64 Million
Q1 2019

May 14, 2019

SELL
$46.36 - $52.63 $129,900 - $147,469
-2,802 Reduced 2.6%
104,777 $5.47 Million
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $1.09 Million - $1.24 Million
26,224 Added 32.23%
107,579 $4.94 Million
Q3 2018

Nov 16, 2018

BUY
$46.76 - $51.24 $793,236 - $869,235
16,964 Added 26.35%
81,355 $3.85 Million
Q2 2018

Aug 15, 2018

BUY
$44.29 - $50.42 $97,438 - $110,924
2,200 Added 3.54%
64,391 $2.95 Million
Q1 2018

May 16, 2018

BUY
$48.49 - $58.14 $2.19 Million - $2.62 Million
45,096 Added 263.8%
62,191 $3.06 Million
Q4 2017

Feb 16, 2018

BUY
$47.53 - $53.73 $812,525 - $918,514
17,095
17,095 $917,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Banco De Sabadell, S.A Portfolio

Follow Banco De Sabadell, S.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.